BNP Paribas Asset Management
THC icon

BNP Paribas Asset Management’s Tenet Healthcare THC Stock Holding History

BNP Paribas Asset Management’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.3M Sell
103,172
-9,562
-8% -$1.76M 0.02% 587
2026
Q1 		$21.3M Buy
112,734
+3,497
+3% +$737K 0.02% 534
2025
Q4 		$21.7M Buy
109,237
+90,424
+481% +$18.3M 0.02% 520
2025
Q3 		$3.82M Sell
18,813
-3,101
-14% -$550K 0.01% 564
2025
Q2 		$3.86M Buy
21,914
+2,035
+10% +$306K 0.01% 614
2025
Q1 		$2.67M Buy
19,879
+2,672
+16% +$352K 0.01% 641
2024
Q4 		$2.17M Sell
17,207
-150
-0.9% -$22.3K 0.01% 691
2024
Q3 		$2.88M Sell
17,357
-16,304
-48% -$2.47M 0.01% 625
2024
Q2 		$4.48M Buy
33,661
+5,721
+20% +$689K 0.01% 541
2024
Q1 		$2.94M Sell
27,940
-3,773
-12% -$339K 0.01% 608
2023
Q4 		$2.4M Sell
31,713
-6,521
-17% -$413K 0.01% 645
2023
Q3 		$2.52M Sell
38,234
-17,405
-31% -$1.3M 0.01% 632
2023
Q2 		$4.53M Sell
55,639
-3,935
-7% -$280K 0.01% 536
2023
Q1 		$3.54M Buy
59,574
+6,806
+13% +$378K 0.01% 593
2022
Q4 		$2.58M Sell
52,768
-2,996
-5% -$138K 0.01% 640
2022
Q3 		$2.88M Buy
55,764
+12,270
+28% +$728K 0.01% 628
2022
Q2 		$2.29M Buy
43,494
+3,487
+9% +$243K 0.01% 692
2022
Q1 		$3.44M Buy
+40,007
New +$3.29M 0.01% 595
2016
Q3 		– Sell
-19,021
Closed -$526K – 1102
2016
Q2 		$526K Hold
19,021
– – ﹤0.01% 958
2016
Q1 		$550K Hold
19,021
– – ﹤0.01% 916
2015
Q4 		$576K Sell
19,021
-19,488
-51% -$639K ﹤0.01% 882
2015
Q3 		$1.42M Buy
38,509
+25,145
+188% +$1.3M 0.01% 755
2015
Q2 		$774K Buy
+13,364
New +$683K 0.01% 879

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

BNP Paribas Asset Management's THC Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Tenet Healthcare (THC) stake by 8.5% in Q2 2026, selling an estimated $1.76M and leaving 103,172 shares worth $19.3M. The position accounts for 0.02% of the portfolio, ranked #587.

BNP Paribas Asset Management first reported a position in THC in Q2 2015 and has held it in 23 quarters since. The position peaked at $21.7M in Q4 2025. 681 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • BNP Paribas Asset Management held 103,172 shares of Tenet Healthcare worth $19.3M as of Q2 2026.
  • BNP Paribas Asset Management sold 9,562 Tenet Healthcare shares in Q2 2026, an estimated $1.76M.
  • Tenet Healthcare made up 0.02% of BNP Paribas Asset Management's portfolio in Q2 2026, its #587 holding.
  • BNP Paribas Asset Management first reported a position in Tenet Healthcare in Q2 2015 and has held it in 23 quarters since.
  • BNP Paribas Asset Management's Tenet Healthcare position peaked at $21.7M in Q4 2025.
  • 681 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.